Written and maintained by CASRAI Editorial Board
Last updated
Note: This guide provides clinical informatics, biostatistical, and research methodology reference information from primary peer-reviewed literature and professional society guidelines. It does not constitute individual medical advice or clinical treatment instructions.
The CURB-65 score is a five-point clinical prediction rule developed and internationally validated by W. S. Lim and colleagues (published in Thorax, 2003) to estimate 30-day all-cause mortality in adults presenting with Community-Acquired Pneumonia (CAP). By assigning one point to each of five readily available clinical and laboratory parameters—Confusion, blood Urea nitrogen elevation, Respiratory rate, low Blood pressure, and age ≥ 65 years—the score stratifies patients into low-, intermediate-, and high-risk mortality tiers that inform site-of-care decisions (outpatient management vs. inpatient medical ward admission vs. intensive care assessment).
In respiratory clinical trials, health services research, and Electronic Health Record (clinical decision support system) design, CURB-65 and its laboratory-free four-point counterpart, CRB-65, serve as standard baseline severity covariates alongside the 20-variable Pneumonia Severity Index (PSI).
What Is the CURB-65 Score? The 5 Point Criteria and Unit Conversions
Lim et al. (2003) derived and validated CURB-65 using prospective data from 1,068 adult patients presenting with community-acquired pneumonia across hospitals in the United Kingdom, New Zealand, and the Netherlands, building on the earlier modified British Thoracic Society (BTS) rule. Each of the five dichotomous variables contributes exactly 1 point, yielding a total score ranging from 0 to 5:
| Criterion Acronym | Clinical / Laboratory Parameter | Exact Threshold Definition (Lim et al., 2003) | Points Assigned |
|---|---|---|---|
| C | Confusion (New-onset cognitive impairment) | Abbreviated Mental Test (AMT) score ≤ 8 (out of 10), or new-onset disorientation to person, place, or time not attributable to baseline dementia. | +1 point |
| U | Urea (Blood Urea / Blood Urea Nitrogen [BUN]) | Serum urea > 7 mmol/L (in SI units), which converts to Blood Urea Nitrogen (BUN) > 19 mg/dL (often operationalized as ≥ 20 mg/dL when laboratories report integer mg/dL). | +1 point |
| R | Respiratory Rate | Respiratory rate ≥ 30 breaths per minute. | +1 point |
| B | Blood Pressure (Systolic or Diastolic Hypotension) | Systolic blood pressure (SBP) < 90 mmHg OR Diastolic blood pressure (DBP) ≤ 60 mmHg (note the strict inequality on SBP vs. ≤ on DBP). | +1 point |
| 65 | Age ≥ 65 Years | Chronological age ≥ 65 years at presentation. | +1 point |
Informatics Unit-Conversion Trap (SI Serum Urea vs. US BUN): When implementing CURB-65 in clinical data warehouses or EHR calculators, informaticists must verify whether the laboratory LOINC code reports molar Urea (mmol/L, standard in the UK, Europe, and Commonwealth countries) or mass Blood Urea Nitrogen (BUN) (mg/dL, standard in the United States). Because one mole of urea contains two moles of nitrogen (molecular weight of nitrogen component = 28.014 g/mol, or 2.8 mg/dL per 1 mmol/L), 7.0 mmol/L × 2.8 = 19.6 mg/dL (hence the > 19 mg/dL BUN cutoff).
CURB-65 30-Day Mortality Stratification and Site-of-Care Risk Tiers
In the international derivation and validation cohorts published by Lim et al. (Thorax, 2003), 30-day all-cause mortality increased monotonically with each additional point on the CURB-65 scale:
| CURB-65 Total Score | 30-Day Mortality (Lim et al., 2003 Combined Cohort) | BTS Risk Group | Standard Guideline Site-of-Care Stratification |
|---|---|---|---|
| 0 points | ~0.6% – 0.7% | Group 1 (Low Severity) | Low risk of death; typically suitable for outpatient/home management unless social or oxygenation factors preclude home care. |
| 1 point | ~2.7% – 3.2% | Group 1 (Low Severity) | Low risk of death; typically suitable for outpatient management. |
| 2 points | ~6.8% – 13.0% (9.2% overall) | Group 2 (Moderate Severity) | Intermediate mortality risk; consider short-stay inpatient hospital admission or closely supervised hospital-at-home / outpatient follow-up. |
| 3 points | ~14.0% – 17.0% (14.5% overall) | Group 3 (High Severity) | Severe CAP; requires inpatient hospitalization with evaluation for Intensive Care Unit (ICU) transfer if physiological instability progresses. |
| 4 or 5 points | ~40% (Score 4) to 57% (Score 5) | Group 3 (High Severity) | Highest mortality risk; urgent inpatient hospitalization and direct assessment for ICU admission. |
CRB-65 in Primary Care and Telehealth Triage Workflows
In ambulatory primary care clinics, urgent care centers without point-of-care chemistry analyzers, and telehealth nursing triage encounters, serum urea/BUN results are not immediately available. Lim et al. (2003) concurrently validated the four-point CRB-65 score (ranging from 0 to 4 points), which relies purely on clinical history and vital signs (Confusion, Respiratory rate ≥ 30/min, Blood pressure < 90 systolic or ≤ 60 diastolic, and age ≥ 65):
- CRB-65 Score
0: Very low 30-day mortality (~0.9%–1.2%); generally does not require hospital admission for clinical severity reasons alone. - CRB-65 Score
1–2: Intermediate mortality risk (~5.3%–12.2%); prompts urgent in-person hospital or emergency department evaluation (where full laboratory testing and pulse oximetry/chest imaging can be obtained). - CRB-65 Score
3–4: High mortality risk (~31%–33%); requires urgent emergency hospital admission.
ATS/IDSA Guidelines: Comparing CURB-65 vs. Pneumonia Severity Index (PSI)
How does CURB-65 compare with the Pneumonia Severity Index (PSI / PORT Score) (Fine et al., NEJM, 1997) in professional clinical guidelines and clinical trial design? In the 2019 American Thoracic Society and Infectious Diseases Society of America (ATS/IDSA) Clinical Practice Guideline for Community-Acquired Pneumonia (Metlay et al., AJRCCM, 2019), the guideline panel evaluated both instruments:
- Bedside Simplicity vs. Granular Comorbidity Weighting: PSI requires evaluating 20 demographic, comorbidity (neoplastic disease, heart failure, cerebrovascular, renal, and liver disease), physical exam, arterial blood gas/oximetry, radiographic (pleural effusion), and chemistry variables to classify patients into Risk Classes I–V. By contrast, CURB-65 uses only 5 binary variables, making it substantially easier to compute at the bedside or abstract retrospectively from minimal datasets.
- Identifying Low-Risk Patients vs. High-Risk Specificity: The 2019 ATS/IDSA guideline notes that PSI identifies a larger proportion of patients as low risk (Classes I–II) with a slightly lower false-negative mortality rate than CURB-65 scores of 0–1, whereas CURB-65 scores ≥ 3 provide a concise, specific marker of acute physiological derangement. Importantly, in older adults, baseline age ≥ 65 automatically assigns +1 point on CURB-65 (and heavy age points on PSI), so geriatric pneumonia trials often pair CURB-65 with functional status measures such as the Clinical Frailty Scale (CFS) and peripheral oxygen saturation (SpO2 < 90%).
- Regulatory Transparent CDS Status: Because CURB-65 and CRB-65 are published, deterministic five-variable rules whose inputs and logic can be independently verified by any clinician at the point of care, EHR calculators that compute CURB-65 and cite Lim et al. (2003) exemplify transparent non-device CDS under FDA CDS guidance.
Frequently Asked Questions
What is the CURB-65 score and how is it used in clinical research and healthcare?
The CURB-65 score is a validated 5-point clinical prediction rule (derived by Lim et al., Thorax 2003) used to stratify 30-day all-cause mortality risk in adults presenting with Community-Acquired Pneumonia (CAP). It assigns 1 point each for Confusion, Urea > 7 mmol/L (BUN > 19 mg/dL), Respiratory rate ≥ 30 breaths/min, Blood pressure < 90 mmHg systolic or ≤ 60 mmHg diastolic, and age ≥ 65 years. In clinical trials and emergency medicine, it standardizes baseline severity stratification and guides outpatient vs. inpatient admission decisions.
What standards or clinical guidelines govern the CURB-65 score?
CURB-65 is endorsed as the primary pneumonia severity stratification tool in the British Thoracic Society (BTS) and NICE pneumonia guidelines, and is evaluated alongside the 20-variable Pneumonia Severity Index (PSI/PORT score) in the 2019 American Thoracic Society and Infectious Diseases Society of America (ATS/IDSA) Community-Acquired Pneumonia Clinical Practice Guideline.
How does the CURB-65 score integrate with EHR and health informatics workflows?
In Electronic Health Record (EHR) clinical decision support systems (CDSS), CURB-65 is implemented as an automated real-time calculator inside emergency department pneumonia order sets: pulling patient age, nursing flowsheet vital signs (respiratory rate, systolic/diastolic blood pressure), confusion assessments, and LOINC serum BUN/urea results to display the mortality tier, while ambulatory and telehealth triage workflows use the 4-point lab-free CRB-65 variant.
